Search PubMed⌕ Search

Biomedical subjects

R Storer

Publications and source records attributed to R Storer.

36 records · Page 2Linked to original sources
PubMed1989

The effect of placement technique upon the compressive strength and porosity of a composite resin.

This paper examines the effect of two placement techniques upon the compressive strength and level of porosity of specimens of a composite resin. Those specimens prepared by a condensation technique had a significantly lower mean compressive strength (P less than 0.05) and value of Weibull modulus (P less than 0.05) than specimens prepared using a smearing technique. No significant differences in the overall mean percentage area occupied by porosity and mean number of pores were demonstrated (P greater than 0.05) between the two placement techniques. Specimens prepared using the smearing technique, however, had significantly smaller mean maximum pore diameters (P less than 0.05) than those prepared using the condensation technique. It is therefore desirable when placing composite resins to reduce to a minimum handling procedures that are likely to influence the levels of porosity within the material.

Composite Resins↗
PubMed1972

Oral cancer.

Explore the source record for details and available documents.

Aged↗
PubMedDate not supplied

Solution-phase combinatorial chemistry.

The use of solution phase techniques has been explored as an alternative to solid-phase chemistry approaches for the preparation of arrays of compounds in the drug discovery process. Solution-phase work is free from some of the constraints of solid-phase approaches but has disadvantages with respect to purification. This article will also illustrate some of the advances made in recent years in solution phase array chemistry including using supported reagents and simple extractive protocols for the effective preparation of high quality samples.

Amides↗
PubMedDate not supplied

Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.

Advances in genetic engineering have created opportunities for improved understanding of the molecular basis of carcinogenesis. Through selective introduction, activation, and inactivation of specific genes, investigators can produce mice of unique genotypes and phenotypes that afford insights into the events and mechanisms responsible for tumor formation. It has been suggested that such animals might be used for routine testing of chemicals to determine their carcinogenic potential because the animals may be mechanistically relevant for understanding and predicting the human response to exposure to the chemical being tested. Before transgenic and knockout mice can be used as an adjunct or alternative to the conventional 2-year rodent bioassay, information related to the animal line to be used, study design, and data analysis and interpretation must be carefully considered. Here, we identify and review such information relative to Tg.AC and rasH2 transgenic mice and p53+/- and XPA-/- knockout mice, all of which have been proposed for use in chemical carcinogenicity testing. In addition, the implications of findings of tumors in transgenic and knockout animals when exposed to chemicals is discussed in the context of human health risk assessment.

Animals↗